Document Details
Form
Filing Date
March 26, 2019
Document Date
March 26, 2019
Form Description
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Filing Group
Registration Statements
Company
Stoke Therapeutics
Issuer
Stoke Therapeutics, Inc.